Aryl sulfonyl compounds as CCR6 inhibitors
US12012403B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2022 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Aug 17, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.